These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23044005)

  • 21. Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
    Bergstra SA; Allaart CF; Stijnen T; Landewé RBM
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1473-1483. PubMed ID: 27992656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.
    Bourré-Tessier J; Haraoui B
    J Rheumatol; 2010 Jul; 37(7):1416-21. PubMed ID: 20436072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
    Yamaguchi R; Tanaka E; Nakajima A; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Sugimoto N; Ikari K; Yamanaka H; Harigai M
    Mod Rheumatol; 2022 Apr; 32(3):522-527. PubMed ID: 34897494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.
    Georgescu L; Quinn GC; Schwartzman S; Paget SA
    Semin Arthritis Rheum; 1997 Jun; 26(6):794-804. PubMed ID: 9213378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A; Lopez-Olivo MA; Maxwell L; Burls A; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD004525. PubMed ID: 23728649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).
    Martínez Lopez JA; Loza E; Carmona L
    Clin Exp Rheumatol; 2009; 27(4):678-84. PubMed ID: 19772806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T; Pincus T
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
    Wang W; Zhou H; Liu L
    Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
    Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
    J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
    Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
    Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.
    Alarcón GS; López-Méndez A; Walter J; Boerbooms AM; Russell AS; Furst DE; Rau R; Drosos AA; Bartolucci AA
    J Rheumatol; 1992 Dec; 19(12):1868-73. PubMed ID: 1345138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
    Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
    Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH
    Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.
    Salliot C; van der Heijde D
    Ann Rheum Dis; 2009 Jul; 68(7):1100-4. PubMed ID: 19060002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
    Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S
    Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.
    Harigai M
    Mod Rheumatol; 2018 Jan; 28(1):1-8. PubMed ID: 28758827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.